Literature DB >> 25863161

The procollagen N-proteinases ADAMTS2, 3 and 14 in pathophysiology.

Mourad Bekhouche1, Alain Colige2.   

Abstract

Collagen fibers are the main components of most of the extracellular matrices where they provide a structural support to cells, tissues and organs. Fibril-forming procollagens are synthetized as individual chains that associate to form homo- or hetero-trimers. They are characterized by the presence of a central triple helical domain flanked by amino and carboxy propeptides. Although there are some exceptions, these two propeptides have to be proteolytically removed to allow the almost spontaneous assembly of the trimers into collagen fibrils and fibers. While the carboxy-propeptide is mainly cleaved by proteinases from the tolloid family, the amino-propeptide is usually processed by procollagen N-proteinases: ADAMTS2, 3 and 14. This review summarizes the current knowledge concerning this subfamily of ADAMTS enzymes and discusses their potential involvement in physiopathological processes that are not directly linked to fibrillar procollagen processing.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  ADAMTS; Fibrillar collagens; Procollagen N-proteinases

Mesh:

Substances:

Year:  2015        PMID: 25863161     DOI: 10.1016/j.matbio.2015.04.001

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  35 in total

Review 1.  ADAMTS proteins in human disorders.

Authors:  Timothy J Mead; Suneel S Apte
Journal:  Matrix Biol       Date:  2018-06-06       Impact factor: 11.583

2.  Differential cleavage of lysyl oxidase by the metalloproteinases BMP1 and ADAMTS2/14 regulates collagen binding through a tyrosine sulfate domain.

Authors:  Tamara Rosell-García; Alberto Paradela; Gema Bravo; Laura Dupont; Mourad Bekhouche; Alain Colige; Fernando Rodriguez-Pascual
Journal:  J Biol Chem       Date:  2019-05-31       Impact factor: 5.157

Review 3.  The "other" 15-40%: The Role of Non-Collagenous Extracellular Matrix Proteins and Minor Collagens in Tendon.

Authors:  Nandaraj Taye; Stylianos Z Karoulias; Dirk Hubmacher
Journal:  J Orthop Res       Date:  2019-08-26       Impact factor: 3.494

Review 4.  Roles of the endoplasmic reticulum-resident, collagen-specific molecular chaperone Hsp47 in vertebrate cells and human disease.

Authors:  Shinya Ito; Kazuhiro Nagata
Journal:  J Biol Chem       Date:  2018-12-12       Impact factor: 5.157

Review 5.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

6.  Label-free quantitative proteomics reveals molecular correlates of altered biomechanical properties in molar incisor hypomineralization (MIH): an in vitro study.

Authors:  U Mukhtar; A Goyal; M Luthra-Guptasarma; K Gauba; A Kapur; A K Thakur
Journal:  Eur Arch Paediatr Dent       Date:  2022-01-10

7.  ADAM and ADAMTS disintegrin and metalloproteinases as major factors and molecular targets in vascular malfunction and disease.

Authors:  HaiFeng Yang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2022-01-24

8.  The development of a mature collagen network in cartilage from human bone marrow stem cells in Transwell culture.

Authors:  Alan D Murdoch; Timothy E Hardingham; David R Eyre; Russell J Fernandes
Journal:  Matrix Biol       Date:  2015-10-30       Impact factor: 11.583

9.  Giantin is required for intracellular N-terminal processing of type I procollagen.

Authors:  Nicola L Stevenson; Dylan J M Bergen; Yinhui Lu; M Esther Prada-Sanchez; Karl E Kadler; Chrissy L Hammond; David J Stephens
Journal:  J Cell Biol       Date:  2021-05-04       Impact factor: 10.539

Review 10.  The quest for substrates and binding partners: A critical barrier for understanding the role of ADAMTS proteases in musculoskeletal development and disease.

Authors:  Brandon Satz-Jacobowitz; Dirk Hubmacher
Journal:  Dev Dyn       Date:  2020-09-17       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.